Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
dose of semaglutide in units TrimRX Reta clinical trial data Vegetarian Dose:1 mg
Reta clinical trial data & dosing — a must read Retatrutide (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP
The bull flag breakout occurred on the breakout through $17.42 as shares peaked at $21.44
Vegetarian
Dose:1 mg
As of mid-2026, Retatrutide is still in Phase 3 trials, with FDA approval expected late this year or early next
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
US$ 27.25
US$ 29.21
US$ 22.79
US$ 25.79
US$ 25.72
US$ 29.36
US$ 26.91
US$ 22.78
US$ 29.74
